Top 100 Contractors in NAICS 3254: Pharmaceutical and Medicine Manufacturing, Aug 2025–Jul 2026

Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe

The latest 12 months. See the newest fiscal year's list: Top Contractors in NAICS 3254: Pharmaceutical and Medicine Manufacturing, FY2025.

The top 10 won 94% of NAICS 3254 contract dollars from August 2025 through July 2026

Ranking facts

Contract obligations
$18,995,655,588 Net of deobligations, by contracts coded NAICS 3254 or a code under it
Contractors
462 Parent companies with an obligation
Largest contractor
Mckesson Corporation $12 billion, 62.2% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $12,015,301,409
Rank history: #2 in FY2021, #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since Aug 2024–Jul 2025.
2 $5,150,098,733
Rank history: #8 in FY2021, #14 in FY2022, #4 in FY2023, #2 in FY2024 and #2 in FY2025; unchanged since Aug 2024–Jul 2025.
3 $248,568,785
Rank history: not on the FY2021–FY2023 lists, #10 in FY2024 and #4 in FY2025; up 4 since Aug 2024–Jul 2025.
4 $224,999,997
Rank history: not on the FY2021–FY2023 lists, #6 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
5 $116,913,851
Rank history: not on the FY2021–FY2023 lists, #17 in FY2024 and #12 in FY2025; up 10 since Aug 2024–Jul 2025.
6 $113,641,157
Rank history: not on the FY2021 list, #19 in FY2022, #20 in FY2023, #11 in FY2024 and #34 in FY2025; up 3 since Aug 2024–Jul 2025.
7 $106,483,712
Rank history: not on the FY2021–FY2024 lists and #9 in FY2025; up 3 since Aug 2024–Jul 2025.
8 $65,536,123
Rank history: #24 in FY2021, #21 in FY2022, #15 in FY2023, #12 in FY2024 and #7 in FY2025; unchanged since Aug 2024–Jul 2025.
9 $62,528,613
Rank history: not on the FY2021–FY2023 lists, #16 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
10 $55,273,060
Rank history: not on the FY2021–FY2023 lists, #13 in FY2024 and #10 in FY2025; new, not ranked in Aug 2024–Jul 2025.
11 $50,162,464
Rank history: not on the FY2021 list, #25 in FY2022, #34 in FY2023, #30 in FY2024 and #16 in FY2025; unchanged since Aug 2024–Jul 2025.
12 $42,247,141
Rank history: not on the FY2021–FY2023 lists, #20 in FY2024 and #15 in FY2025; up 4 since Aug 2024–Jul 2025.
13 $39,954,565
Rank history: #16 in FY2021, #17 in FY2022, #11 in FY2023, #22 in FY2024 and #14 in FY2025; up 5 since Aug 2024–Jul 2025.
14 $38,563,113
Rank history: not on the FY2021 list, #46 in FY2022, #31 in FY2023, #23 in FY2024 and #18 in FY2025; up 5 since Aug 2024–Jul 2025.
15 $36,658,160
Rank history: #53 in FY2021, not on the FY2022 list, #43 in FY2023, #48 in FY2024 and #8 in FY2025; down 2 since Aug 2024–Jul 2025.
16 $34,050,073
Rank history: not on the FY2021 list, #16 in FY2022, #48 in FY2023, not on the FY2024 list and #6 in FY2025; down 2 since Aug 2024–Jul 2025.
17 $33,392,936
Rank history: #35 in FY2021, not on the FY2022–FY2024 lists and #21 in FY2025; new, not ranked in Aug 2024–Jul 2025.
18
Novartis Pharmaceuticals Corporation 2 awardees
$31,536,941
Rank history: not on the FY2021–FY2024 lists and #22 in FY2025; up 7 since Aug 2024–Jul 2025.
19 $31,231,306
Rank history: #30 in FY2021, #33 in FY2022, #24 in FY2023, #21 in FY2024 and #17 in FY2025; down 2 since Aug 2024–Jul 2025.
20 $29,998,678
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
21 $29,123,275
Rank history: not on the FY2021–FY2023 lists, #47 in FY2024 and #30 in FY2025; up 33 since Aug 2024–Jul 2025.
22 $21,753,133
Rank history: #29 in FY2021, #22 in FY2022, #22 in FY2023, #26 in FY2024 and #27 in FY2025; up 17 since Aug 2024–Jul 2025.
23 $19,172,645
Rank history: not on the FY2021–FY2023 lists, #18 in FY2024 and #13 in FY2025; down 11 since Aug 2024–Jul 2025.
24 $17,668,302
Rank history: #20 in FY2021, #24 in FY2022, #28 in FY2023, #19 in FY2024 and #23 in FY2025; unchanged since Aug 2024–Jul 2025.
25 $16,795,109
Rank history: not on the FY2021–FY2024 lists and #24 in FY2025; up 256 since Aug 2024–Jul 2025.
26 $16,635,101
Rank history: not on the FY2021–FY2023 lists, #24 in FY2024 and #26 in FY2025; down 6 since Aug 2024–Jul 2025.
27 $15,716,185
Rank history: not on the FY2021–FY2022 lists, #57 in FY2023, not on the FY2024 list and #25 in FY2025; up 169 since Aug 2024–Jul 2025.
28 $15,120,000
Rank history: not on the FY2021–FY2024 lists and #49 in FY2025; up 320 since Aug 2024–Jul 2025.
29 $11,293,751
Rank history: not on the FY2021–FY2024 lists and #42 in FY2025; up 84 since Aug 2024–Jul 2025.
30 $9,689,594
Rank history: not on the FY2021–FY2025 lists; up 171 since Aug 2024–Jul 2025.
31 $9,600,171
Rank history: #14 in FY2021, #40 in FY2022, #42 in FY2023, #45 in FY2024 and #38 in FY2025; up 10 since Aug 2024–Jul 2025.
32 $9,577,113
Rank history: #28 in FY2021, not on the FY2022–FY2023 lists, #27 in FY2024 and #39 in FY2025; down 9 since Aug 2024–Jul 2025.
33 $9,412,734
Rank history: not on the FY2021–FY2023 lists, #81 in FY2024 and #28 in FY2025; down 2 since Aug 2024–Jul 2025.
34 $8,832,811
Rank history: not on the FY2021–FY2023 lists, #99 in FY2024 and #33 in FY2025; up 2 since Aug 2024–Jul 2025.
35 $8,700,000
Rank history: not on the FY2021–FY2023 lists, #37 in FY2024 and #32 in FY2025; down 6 since Aug 2024–Jul 2025.
36 $8,497,167
Rank history: not on the FY2021 list, #85 in FY2022, #69 in FY2023, #56 in FY2024 and #51 in FY2025; up 16 since Aug 2024–Jul 2025.
37 $8,182,250
Rank history: #9 in FY2021, #7 in FY2022, #63 in FY2023, #14 in FY2024 and #19 in FY2025; up 96 since Aug 2024–Jul 2025.
38 $8,023,891
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
39 $7,865,740
Rank history: not on the FY2021 list, #75 in FY2022, not on the FY2023–FY2024 lists and #35 in FY2025; new, not ranked in Aug 2024–Jul 2025.
40 $7,615,500
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
41 $7,611,895
Rank history: #6 in FY2021, #5 in FY2022, #7 in FY2023, not on the FY2024 list and #31 in FY2025; down 4 since Aug 2024–Jul 2025.
42 $6,962,890
Rank history: not on the FY2021–FY2023 lists, #63 in FY2024 and #41 in FY2025; down 4 since Aug 2024–Jul 2025.
43 $6,863,811
Rank history: #66 in FY2021, #60 in FY2022, #56 in FY2023, #68 in FY2024 and #44 in FY2025; up 6 since Aug 2024–Jul 2025.
44 $6,856,159
Rank history: not on the FY2021–FY2023 lists, #53 in FY2024 and #36 in FY2025; down 9 since Aug 2024–Jul 2025.
45 $6,187,685
Rank history: not on the FY2021–FY2023 lists, #38 in FY2024 and #47 in FY2025; up 70 since Aug 2024–Jul 2025.
46 $4,974,870
Rank history: not on the FY2021–FY2024 lists and #52 in FY2025; new, not ranked in Aug 2024–Jul 2025.
47 $4,691,131
Rank history: #42 in FY2021, #47 in FY2022, #55 in FY2023, #41 in FY2024 and #43 in FY2025; up 18 since Aug 2024–Jul 2025.
48 $4,507,247
Rank history: #79 in FY2021, #94 in FY2022, #58 in FY2023, #55 in FY2024 and #48 in FY2025; down 3 since Aug 2024–Jul 2025.
49
Boehringer Ingelheim Animal Health USA Inc
$4,464,366
Rank history: not on the FY2021–FY2022 lists, #61 in FY2023, #46 in FY2024 and #40 in FY2025; down 16 since Aug 2024–Jul 2025.
50 $4,443,100
Rank history: not on the FY2021–FY2024 lists and #59 in FY2025; up 19 since Aug 2024–Jul 2025.
51 $4,276,720
Rank history: not on the FY2021–FY2024 lists and #55 in FY2025; up 2 since Aug 2024–Jul 2025.
52 $4,199,659
Rank history: #98 in FY2021, #72 in FY2022, #74 in FY2023, not on the FY2024 list and #60 in FY2025; new, not ranked in Aug 2024–Jul 2025.
53 $4,148,102
Rank history: not on the FY2021–FY2023 lists, #97 in FY2024 and #56 in FY2025; down 3 since Aug 2024–Jul 2025.
54 $3,904,785
Rank history: not on the FY2021–FY2023 lists, #47 in FY2024 and #20 in FY2025; down 32 since Aug 2024–Jul 2025.
55 $3,696,281
Rank history: #56 in FY2021, #54 in FY2022, #45 in FY2023, #50 in FY2024 and #54 in FY2025; down 8 since Aug 2024–Jul 2025.
56 $3,627,452
Rank history: #57 in FY2021, #44 in FY2022, not on the FY2023–FY2024 lists and #58 in FY2025; down 5 since Aug 2024–Jul 2025.
57 $3,568,334
Rank history: not on the FY2021–FY2024 lists and #72 in FY2025; up 11 since Aug 2024–Jul 2025.
58 $3,330,499
Rank history: not on the FY2021–FY2025 lists; up 134 since Aug 2024–Jul 2025.
59 $3,139,410
Rank history: not on the FY2021–FY2024 lists and #82 in FY2025; up 37 since Aug 2024–Jul 2025.
60 $2,945,487
Rank history: not on the FY2021–FY2023 lists, #8 in FY2024 and #57 in FY2025; down 54 since Aug 2024–Jul 2025.
61 $2,699,725
Rank history: #92 in FY2021, #79 in FY2022, #80 in FY2023, #70 in FY2024 and #68 in FY2025; up 6 since Aug 2024–Jul 2025.
62 $2,651,492
Rank history: not on the FY2021–FY2023 lists, #64 in FY2024 and #63 in FY2025; up 1 since Aug 2024–Jul 2025.
63 $2,468,330
Rank history: #65 in FY2021, #66 in FY2022, #49 in FY2023, #59 in FY2024 and #45 in FY2025; down 21 since Aug 2024–Jul 2025.
64 $2,291,692
Rank history: not on the FY2021–FY2024 lists and #69 in FY2025; up 18 since Aug 2024–Jul 2025.
65 $2,171,611
Rank history: not on the FY2021–FY2022 lists, #90 in FY2023, not on the FY2024 list and #11 in FY2025; up 43 since Aug 2024–Jul 2025.
66 $2,166,357
Rank history: not on the FY2021–FY2022 lists, #70 in FY2023, #86 in FY2024 and #78 in FY2025; up 26 since Aug 2024–Jul 2025.
67 $2,128,314
Rank history: #90 in FY2021, #67 in FY2022, not on the FY2023 list, #54 in FY2024 and not on the FY2025 list; down 6 since Aug 2024–Jul 2025.
68 $2,120,671
Rank history: #72 in FY2021, #69 in FY2022, #71 in FY2023, #96 in FY2024 and #74 in FY2025; up 11 since Aug 2024–Jul 2025.
69 $2,097,799
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
70 $1,999,670
Rank history: #49 in FY2021, #64 in FY2022, #67 in FY2023, #71 in FY2024 and #66 in FY2025; down 6 since Aug 2024–Jul 2025.
71 $1,990,001
Rank history: not on the FY2021–FY2025 lists; up 19 since Aug 2024–Jul 2025.
72 $1,960,300
Rank history: not on the FY2021–FY2025 lists; up 115 since Aug 2024–Jul 2025.
73 $1,933,538
Rank history: not on the FY2021–FY2024 lists and #71 in FY2025; down 3 since Aug 2024–Jul 2025.
74 $1,844,468
Rank history: #48 in FY2021, #61 in FY2022, #82 in FY2023, not on the FY2024 list and #87 in FY2025; up 20 since Aug 2024–Jul 2025.
75
American Regent Inc
$1,804,958
Rank history: not on the FY2021–FY2024 lists and #79 in FY2025; up 72 since Aug 2024–Jul 2025.
76 $1,794,913
Rank history: not on the FY2021–FY2022 lists, #96 in FY2023, #98 in FY2024 and #76 in FY2025; unchanged since Aug 2024–Jul 2025.
77 $1,759,579
Rank history: not on the FY2021–FY2025 lists; up 68 since Aug 2024–Jul 2025.
78 $1,733,234
Rank history: #1 in FY2021, #1 in FY2022, #2 in FY2023, not on the FY2024 list and #73 in FY2025; new, not ranked in Aug 2024–Jul 2025.
79
Jubilant Hollisterstier LLC 2 awardees, including Jubilant Draximage Inc.
$1,674,707
Rank history: not on the FY2021–FY2025 lists; up 31 since Aug 2024–Jul 2025.
80 $1,640,546
Rank history: not on the FY2021–FY2024 lists and #81 in FY2025; down 6 since Aug 2024–Jul 2025.
81 $1,621,974
Rank history: #99 in FY2021, #70 in FY2022, #65 in FY2023, #72 in FY2024 and #67 in FY2025; down 9 since Aug 2024–Jul 2025.
82 $1,616,172
Rank history: #93 in FY2021, #89 in FY2022, #88 in FY2023, #79 in FY2024 and #96 in FY2025; up 19 since Aug 2024–Jul 2025.
83
Curia Global Inc.
$1,548,154
Rank history: not on the FY2021–FY2022 lists, #91 in FY2023, not on the FY2024 list and #84 in FY2025; up 26 since Aug 2024–Jul 2025.
84 $1,534,905
Rank history: #75 in FY2021, #81 in FY2022, #86 in FY2023, #82 in FY2024 and #89 in FY2025; up 4 since Aug 2024–Jul 2025.
85 $1,533,384
Rank history: #39 in FY2021, #20 in FY2022, #62 in FY2023, #88 in FY2024 and not on the FY2025 list; up 215 since Aug 2024–Jul 2025.
86 $1,522,263
Rank history: #89 in FY2021 and not on the FY2022–FY2025 lists; up 45 since Aug 2024–Jul 2025.
87 $1,512,816
Rank history: not on the FY2021–FY2024 lists and #83 in FY2025; down 2 since Aug 2024–Jul 2025.
88 $1,458,570
Rank history: not on the FY2021–FY2025 lists; up 356 since Aug 2024–Jul 2025.
89 $1,390,565
Rank history: not on the FY2021–FY2023 lists, #80 in FY2024 and not on the FY2025 list; up 32 since Aug 2024–Jul 2025.
90 $1,268,377
Rank history: not on the FY2021–FY2025 lists; up 115 since Aug 2024–Jul 2025.
91 $1,257,796
Rank history: not on the FY2021–FY2024 lists and #86 in FY2025; unchanged since Aug 2024–Jul 2025.
92 $1,257,159
Rank history: not on the FY2021 list, #71 in FY2022 and not on the FY2023–FY2025 lists; up 79 since Aug 2024–Jul 2025.
93 $1,231,578
Rank history: #63 in FY2021, #99 in FY2022, #89 in FY2023, not on the FY2024 list and #80 in FY2025; up 10 since Aug 2024–Jul 2025.
94 $1,223,169
Rank history: not on the FY2021–FY2022 lists, #93 in FY2023, #84 in FY2024 and not on the FY2025 list; up 57 since Aug 2024–Jul 2025.
95 $1,105,863
Rank history: not on the FY2021–FY2025 lists; up 153 since Aug 2024–Jul 2025.
96 $1,082,137
Rank history: not on the FY2021–FY2025 lists; up 83 since Aug 2024–Jul 2025.
97 $1,058,855
Rank history: not on the FY2021–FY2025 lists; up 25 since Aug 2024–Jul 2025.
98 $1,036,397
Rank history: not on the FY2021–FY2023 lists, #31 in FY2024 and not on the FY2025 list; down 72 since Aug 2024–Jul 2025.
99 $959,715
Rank history: not on the FY2021–FY2025 lists; up 3 since Aug 2024–Jul 2025.
100
Priority Healthcare Distribution Inc. 2 awardees
$950,394
Rank history: not on the FY2021–FY2023 lists, #100 in FY2024 and #93 in FY2025; up 4 since Aug 2024–Jul 2025.
Show 75 more

100 of 462 contractors listed here. See the rest on GovTribe.

Rankings for the codes under NAICS 3254

Code Net obligations Largest contractor
32541 Pharmaceutical and Medicine Manufacturing $18,995,655,588 Mckesson Corporation

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $19.3 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 3254 contractors in Aug 2025–Jul 2026?

1. Mckesson Corporation ($12B), 2. Cencora, Inc. ($5.15B), 3. Emergent Biosolutions Inc. ($249M), 4. Analytic Services Inc. ($225M), 5. Meridian Medical Technologies LLC ($117M), 6. Phlow Corp. ($114M), 7. Exelan Pharmaceuticals Inc. ($106M), 8. Government of the United States ($65.5M), 9. Roche Holdings Inc. ($62.5M), 10. Nighthawk Biosciences, Inc. ($55.3M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work